Escherichia coli (E. coli) are rod-shaped gram-negative bacteria that are commonly found in the environment, foods, and intestines of warm-blooded animals. Most of the E.coli strains are usually harmless to humans, but some strains identified to cause serious some medical complications like gastrointestinal tract infections, cholangitis, cholecystitis, bacteremia, neonatal meningitis and pneumonia, urinary tract infection (UTI), and mostly spread via contaminated food or water.
The global market for E. Coli Testing was estimated to be worth US$ 1 million in 2023 and is forecast to a readjusted size of US$ 2 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030
Emphasis on hygiene, increasing government support for E. coli testing, rising occurrence and high morbidity of E. coli infection worldwide is expected to drive the future market growth of E. coli testing. Technological advancement together with rising use of polymerase chain reaction (PCR) tests for environment water testing predicted to open up new growth possibility during the forecast period.
Report Scope
This report aims to provide a comprehensive presentation of the global market for E. Coli Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of E. Coli Testing by region & country, by Type, and by Application.
The E. Coli Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding E. Coli Testing.
Market Segmentation
By Company
Abbott Laboratories
Meridian Bioscience
Johnson & Johnson
Danaher Corporation
Bio-Rad Laboratories
Enzo Life Sciences
Hologic
Dickinson and Company
Olympus Corporation
Novartis
Segment by Type:
Monoclonal Antibodies
Molecular Diagnostics
Immunoassay
Differential Light Scattering
Others
Segment by Application
Waste Water Treatment
Hospitals and Diagnostic Centers
Research Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of E. Coli Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of E. Coli Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of E. Coli Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 E. Coli Testing Product Introduction
1.2 Global E. Coli Testing Market Size Forecast
1.3 E. Coli Testing Market Trends & Drivers
1.3.1 E. Coli Testing Industry Trends
1.3.2 E. Coli Testing Market Drivers & Opportunity
1.3.3 E. Coli Testing Market Challenges
1.3.4 E. Coli Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global E. Coli Testing Players Revenue Ranking (2023)
2.2 Global E. Coli Testing Revenue by Company (2019-2024)
2.3 Key Companies E. Coli Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies E. Coli Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of E. Coli Testing
2.6 E. Coli Testing Market Competitive Analysis
2.6.1 E. Coli Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by E. Coli Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in E. Coli Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Monoclonal Antibodies
3.1.2 Molecular Diagnostics
3.1.3 Immunoassay
3.1.4 Differential Light Scattering
3.1.5 Others
3.2 Global E. Coli Testing Sales Value by Type
3.2.1 Global E. Coli Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global E. Coli Testing Sales Value, by Type (2019-2030)
3.2.3 Global E. Coli Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Waste Water Treatment
4.1.2 Hospitals and Diagnostic Centers
4.1.3 Research Laboratories
4.1.4 Others
4.2 Global E. Coli Testing Sales Value by Application
4.2.1 Global E. Coli Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global E. Coli Testing Sales Value, by Application (2019-2030)
4.2.3 Global E. Coli Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global E. Coli Testing Sales Value by Region
5.1.1 Global E. Coli Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global E. Coli Testing Sales Value by Region (2019-2024)
5.1.3 Global E. Coli Testing Sales Value by Region (2025-2030)
5.1.4 Global E. Coli Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America E. Coli Testing Sales Value, 2019-2030
5.2.2 North America E. Coli Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe E. Coli Testing Sales Value, 2019-2030
5.3.2 Europe E. Coli Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific E. Coli Testing Sales Value, 2019-2030
5.4.2 Asia Pacific E. Coli Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America E. Coli Testing Sales Value, 2019-2030
5.5.2 South America E. Coli Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa E. Coli Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa E. Coli Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions E. Coli Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions E. Coli Testing Sales Value
6.3 United States
6.3.1 United States E. Coli Testing Sales Value, 2019-2030
6.3.2 United States E. Coli Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States E. Coli Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe E. Coli Testing Sales Value, 2019-2030
6.4.2 Europe E. Coli Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe E. Coli Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China E. Coli Testing Sales Value, 2019-2030
6.5.2 China E. Coli Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China E. Coli Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan E. Coli Testing Sales Value, 2019-2030
6.6.2 Japan E. Coli Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan E. Coli Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea E. Coli Testing Sales Value, 2019-2030
6.7.2 South Korea E. Coli Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea E. Coli Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia E. Coli Testing Sales Value, 2019-2030
6.8.2 Southeast Asia E. Coli Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia E. Coli Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India E. Coli Testing Sales Value, 2019-2030
6.9.2 India E. Coli Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India E. Coli Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories E. Coli Testing Products, Services and Solutions
7.1.4 Abbott Laboratories E. Coli Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Meridian Bioscience
7.2.1 Meridian Bioscience Profile
7.2.2 Meridian Bioscience Main Business
7.2.3 Meridian Bioscience E. Coli Testing Products, Services and Solutions
7.2.4 Meridian Bioscience E. Coli Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Meridian Bioscience Recent Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Profile
7.3.2 Johnson & Johnson Main Business
7.3.3 Johnson & Johnson E. Coli Testing Products, Services and Solutions
7.3.4 Johnson & Johnson E. Coli Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Danaher Corporation Recent Developments
7.4 Danaher Corporation
7.4.1 Danaher Corporation Profile
7.4.2 Danaher Corporation Main Business
7.4.3 Danaher Corporation E. Coli Testing Products, Services and Solutions
7.4.4 Danaher Corporation E. Coli Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Danaher Corporation Recent Developments
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Profile
7.5.2 Bio-Rad Laboratories Main Business
7.5.3 Bio-Rad Laboratories E. Coli Testing Products, Services and Solutions
7.5.4 Bio-Rad Laboratories E. Coli Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Bio-Rad Laboratories Recent Developments
7.6 Enzo Life Sciences
7.6.1 Enzo Life Sciences Profile
7.6.2 Enzo Life Sciences Main Business
7.6.3 Enzo Life Sciences E. Coli Testing Products, Services and Solutions
7.6.4 Enzo Life Sciences E. Coli Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Enzo Life Sciences Recent Developments
7.7 Hologic
7.7.1 Hologic Profile
7.7.2 Hologic Main Business
7.7.3 Hologic E. Coli Testing Products, Services and Solutions
7.7.4 Hologic E. Coli Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Hologic Recent Developments
7.8 Dickinson and Company
7.8.1 Dickinson and Company Profile
7.8.2 Dickinson and Company Main Business
7.8.3 Dickinson and Company E. Coli Testing Products, Services and Solutions
7.8.4 Dickinson and Company E. Coli Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Dickinson and Company Recent Developments
7.9 Olympus Corporation
7.9.1 Olympus Corporation Profile
7.9.2 Olympus Corporation Main Business
7.9.3 Olympus Corporation E. Coli Testing Products, Services and Solutions
7.9.4 Olympus Corporation E. Coli Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Olympus Corporation Recent Developments
7.10 Novartis
7.10.1 Novartis Profile
7.10.2 Novartis Main Business
7.10.3 Novartis E. Coli Testing Products, Services and Solutions
7.10.4 Novartis E. Coli Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Novartis Recent Developments
8 Industry Chain Analysis
8.1 E. Coli Testing Industrial Chain
8.2 E. Coli Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 E. Coli Testing Sales Model
8.5.2 Sales Channel
8.5.3 E. Coli Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Abbott Laboratories
Meridian Bioscience
Johnson & Johnson
Danaher Corporation
Bio-Rad Laboratories
Enzo Life Sciences
Hologic
Dickinson and Company
Olympus Corporation
Novartis
听
听
*If Applicable.
